Long-term follow-up of patients with ATL after autologous stem cell transplantation

Atae Utsunomiya; Masahito Tokunaga; Nobuaki Nakano; Hiroshi Fujiwara; Toshihiro Miyamoto; Masao Ogata; Yasuhiko Miyazaki; Kenji Ishitsuka; Emiko Sakaida; Hirofumi Taji; Toshio Wakayama; Tatsuo Ichinohe; Takahiro Fukuda; Yoshiko Atsuta; Koji Kato; Makoto Yoshimitsu

doi:10.1038/s41409-021-01412-9

Long-term follow-up of patients with ATL after autologous stem cell transplantation

Atae Utsunomiya, Masahito Tokunaga, Nobuaki Nakano, Hiroshi Fujiwara, Toshihiro Miyamoto, Masao Ogata, Yasuhiko Miyazaki, Kenji Ishitsuka, Emiko Sakaida, Hirofumi Taji, Toshio Wakayama, Tatsuo Ichinohe, Takahiro Fukuda, Yoshiko Atsuta, Koji Kato, Makoto Yoshimitsu

Hematology, Oncology & Cardiovascular medicine

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	323-325
Number of pages	3
Journal	Bone Marrow Transplantation
Volume	57
Issue number	2
DOIs	https://doi.org/10.1038/s41409-021-01412-9
Publication status	Published - Feb 2022

All Science Journal Classification (ASJC) codes

Hematology
Transplantation

Access to Document

10.1038/s41409-021-01412-9

Cite this

Utsunomiya, A., Tokunaga, M., Nakano, N., Fujiwara, H., Miyamoto, T., Ogata, M., Miyazaki, Y., Ishitsuka, K., Sakaida, E., Taji, H., Wakayama, T., Ichinohe, T., Fukuda, T., Atsuta, Y., Kato, K., & Yoshimitsu, M. (2022). Long-term follow-up of patients with ATL after autologous stem cell transplantation. Bone Marrow Transplantation, 57(2), 323-325. https://doi.org/10.1038/s41409-021-01412-9

Utsunomiya, A, Tokunaga, M, Nakano, N, Fujiwara, H, Miyamoto, T, Ogata, M, Miyazaki, Y, Ishitsuka, K, Sakaida, E, Taji, H, Wakayama, T, Ichinohe, T, Fukuda, T, Atsuta, Y, Kato, K & Yoshimitsu, M 2022, 'Long-term follow-up of patients with ATL after autologous stem cell transplantation', Bone Marrow Transplantation, vol. 57, no. 2, pp. 323-325. https://doi.org/10.1038/s41409-021-01412-9

@article{941b245cbf1344b7845e0a4e5e863098,

title = "Long-term follow-up of patients with ATL after autologous stem cell transplantation",

author = "Atae Utsunomiya and Masahito Tokunaga and Nobuaki Nakano and Hiroshi Fujiwara and Toshihiro Miyamoto and Masao Ogata and Yasuhiko Miyazaki and Kenji Ishitsuka and Emiko Sakaida and Hirofumi Taji and Toshio Wakayama and Tatsuo Ichinohe and Takahiro Fukuda and Yoshiko Atsuta and Koji Kato and Makoto Yoshimitsu",

note = "Funding Information: The authors thank all physicians who performed autologous stem cell transplantation for patients with adult T-cell leukemia/lymphoma (ATL). The authors also appreciate the data managers at the Japan Society for Hematopoietic Cell Transplantation (JSHCT), and all the members of the JSHCT ATL working group. This study was partially supported by practical research programs of the Japan Agency for Medical Research and Development (AMED) (grant numbers: 20ck0106482h0002, 21ck0106616h0002, 20ck0106616h0001, 21ck0106482h0003). Funding Information: HF is a member of a department endowed by BrightPath Biotherapeutics. TI has received research funding outside the scope of this work from the following companies: Astellas Pharma; Chugai Pharmaceutical; CSL Behring; Eisai; FUJIFILM Wako Chemicals; Kyowa Kirin; Ono Pharmaceutical; Pfizer; Nippon Shinyaku; MSD; Otsuka Pharmaceutical; Repertoire Genesis; Sumitomo Dainippon Pharma; Taiho Pharmaceutical; Takara Bio; Takeda Pharmaceutical; and Zenyaku Kogyo. The other authors declare that they have no competing interests.",

year = "2022",

month = feb,

doi = "10.1038/s41409-021-01412-9",

language = "English",

volume = "57",

pages = "323--325",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Long-term follow-up of patients with ATL after autologous stem cell transplantation

AU - Utsunomiya, Atae

AU - Tokunaga, Masahito

AU - Nakano, Nobuaki

AU - Fujiwara, Hiroshi

AU - Miyamoto, Toshihiro

AU - Ogata, Masao

AU - Miyazaki, Yasuhiko

AU - Ishitsuka, Kenji

AU - Sakaida, Emiko

AU - Taji, Hirofumi

AU - Wakayama, Toshio

AU - Ichinohe, Tatsuo

AU - Fukuda, Takahiro

AU - Atsuta, Yoshiko

AU - Kato, Koji

AU - Yoshimitsu, Makoto

N1 - Funding Information: The authors thank all physicians who performed autologous stem cell transplantation for patients with adult T-cell leukemia/lymphoma (ATL). The authors also appreciate the data managers at the Japan Society for Hematopoietic Cell Transplantation (JSHCT), and all the members of the JSHCT ATL working group. This study was partially supported by practical research programs of the Japan Agency for Medical Research and Development (AMED) (grant numbers: 20ck0106482h0002, 21ck0106616h0002, 20ck0106616h0001, 21ck0106482h0003). Funding Information: HF is a member of a department endowed by BrightPath Biotherapeutics. TI has received research funding outside the scope of this work from the following companies: Astellas Pharma; Chugai Pharmaceutical; CSL Behring; Eisai; FUJIFILM Wako Chemicals; Kyowa Kirin; Ono Pharmaceutical; Pfizer; Nippon Shinyaku; MSD; Otsuka Pharmaceutical; Repertoire Genesis; Sumitomo Dainippon Pharma; Taiho Pharmaceutical; Takara Bio; Takeda Pharmaceutical; and Zenyaku Kogyo. The other authors declare that they have no competing interests.

PY - 2022/2

Y1 - 2022/2

UR - http://www.scopus.com/inward/record.url?scp=85123492560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85123492560&partnerID=8YFLogxK

U2 - 10.1038/s41409-021-01412-9

DO - 10.1038/s41409-021-01412-9

M3 - Letter

C2 - 35066568

AN - SCOPUS:85123492560

SN - 0268-3369

VL - 57

SP - 323

EP - 325

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 2

ER -

Long-term follow-up of patients with ATL after autologous stem cell transplantation

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this